UCB4144

Ligand id: 9806

Name: UCB4144

Classification
Compound class Antibody
Synonyms
abrezekimab (proposed INN) | CDP7766 | UCB-4144 | VR-942
Comments
UCB4144 is an aniti-IL-13 monoclonal being developed as an anti-asthmatic agent. Peptide sequences submitted to the WHO for the proposed INN abrezekimab, match sequences claimed in UCB Pharma patent US8691233, namely sequence IDs 35 and 27 of the preferred antibody named Ab652 in the patent submission [1].
Database Links
Specialist databases
IMGT/mAb-DB 804
Other databases
GtoPdb PubChem SID 354702278